Contact Us
Drug Search Results
More Filters [+]

TAK-085

Alternative Names: tak-085, tak085, tak 085
Latest Update: 2019-05-06
Latest Update Note: Clinical Trial Update

Product Description

TAK-085 is an oral capsule medicine licensed to Takeda Pharmaceutical Company Ltd. TAK-085 contains omega-3 fatty acid ethyl (mainly, ethyl eicosapentaenoate (EPA-E) and ethyl docosahexaenoic acid (DHA-E)). (Sourced from: https://clinicaltrials.gov/ct2/show/NCT01350999)

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Takeda
Company Location: TOKYO M0 103-8668
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for TAK-085

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Hyperlipidemia|Hyperlipoproteinemias

Phase 3: Hypertriglyceridemia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
JapicCTI-163322

N/A

Completed

Hyperlipidemia

2017-08-30

Oasis Flow

P4

Completed

Hyperlipidemia|Hyperlipoproteinemias

2017-08-19

TAK-085/OCT-001

P3

Completed

Hypertriglyceridemia

2011-01-01

TAK-085/CCT-002

P3

Completed

Hypertriglyceridemia

2010-12-01

Recent News Events

Date

Type

Title

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions